Business ❯ Corporate Governance ❯ Accountability

Investor Relations

Shareholder Rights Financial Reporting Fraud Prevention Securities Compliance Whistleblower Programs Securities Fraud

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

Investors have until May 5, 2026 to seek lead-plaintiff status in a case alleging misstatements about the Prader–Willi syndrome drug’s risks.

Blue Owl Securities Suits Draw Fresh Investor Notices as Lead-Plaintiff Deadline Nears

Bitdeer Investors Urged to Seek Counsel as Securities Class Action Nears Lead‑Plaintiff Deadline